Bluebird Bio Has Signed A Second Outcomes-Based Agreement For LYFGENIA, Bringing The Total Number Of Covered Lives To ~200M, And Will Provide Updates On The Commercial Launch At The 42nd Annual J.P. Morgan Healthcare Conference.
Benzinga Newsdesk - Jan 4, 2024, 8:09AM